High-pressure polymorphism in pyridine.
Nico GiordanoChristine M BeaversBranton J CampbellVáclav EignerEugene GregoryanzWilliam George MarshallMiriam Peña-ÁlvarezSimon J TeatCara E VennariSimon ParsonsPublished in: IUCrJ (2020)
Single crystals of the high-pressure phases II and III of pyridine have been obtained by in situ crystallization at 1.09 and 1.69 GPa, revealing the crystal structure of phase III for the first time using X-ray diffraction. Phase II crystallizes in P212121 with Z' = 1 and phase III in P41212 with Z' = ½. Neutron powder diffraction experiments using pyridine-d5 establish approximate equations of state of both phases. The space group and unit-cell dimensions of phase III are similar to the structures of other simple compounds with C 2v molecular symmetry, and the phase becomes stable at high pressure because it is topologically close-packed, resulting in a lower molar volume than the topologically body-centred cubic phase II. Phases II and III have been observed previously by Raman spectroscopy, but have been mis-identified or inconsistently named. Raman spectra collected on the same samples as used in the X-ray experiments establish the vibrational characteristics of both phases unambiguously. The pyridine molecules interact in both phases through CH⋯π and CH⋯N interactions. The nature of individual contacts is preserved through the phase transition between phases III and II, which occurs on decompression. A combination of rigid-body symmetry mode analysis and density functional theory calculations enables the soft vibrational lattice mode which governs the transformation to be identified.
Keyphrases
- phase iii
- phase ii
- density functional theory
- open label
- clinical trial
- raman spectroscopy
- molecular dynamics
- double blind
- placebo controlled
- high resolution
- molecular dynamics simulations
- room temperature
- magnetic resonance imaging
- cell therapy
- magnetic resonance
- randomized controlled trial
- computed tomography
- bone marrow
- single cell
- energy transfer
- dual energy
- minimally invasive
- single molecule
- mesenchymal stem cells